The difference in prognosis correlated with BCA2 over-expression, which alternatively promotes the cell death of ER-positive breast cancers in association with functional DNA damage checkpoints, leading to negative regional recurrence of breast cancers [11]. This evidence concerns the gene RNF115 and breast carcinoma.